Published • loading... • Updated
Medicines Wegovy and Mounjaro: the Risks to Be Known
Summary by economiematin.fr
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
On Thursday, May 28, 2026, the Minister of Health Stéphanie Rist formalized the arrival of the reimbursement of Wegovy and Mounjaro medicines for certain patients with severe obesity. These treatments were previously available only on prescription but without financial support. The device will concern patients with a body mass index of at least 35 with an associated disease, or a BMI of 40 or more. Thus, this medical advance opens up new perspec…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
